PATENT CLAIM ANALYSIS

Application Number: 15903615
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "220000"]

Abstract:
Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.

Claim (Index 10):
The pharmaceutical composition of  claim 2 , wherein the first pharmaceutically active compound is medazolam, the second pharmaceutically active compound is ketamine and the third pharmaceutically active compound is ondansentron, wherein the medazolam:ketamine:ondansentron ratio is about 3:25:2 by mass.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 88.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15903529', '15066731', '14254136', '10428341', '14415322']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7440512544156327
- 35 USC 102 Novelty (BERT): 0.5193969689962721
- Combined Prediction Score: 0.7215858258736966
- Mean Citation Score: 193.753596
- Max Citation Score: 319.43558
- Similarity Product: 272.85113573072675

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test